Sensus Healthcare, Inc. (SRTS)
SRTS moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How SRTS actually reacts to news — the realized, point-in-time move the market made, measured across 217 labeled events over the last three years with zero look-ahead.
SRTS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 183 |
| 30-min | 0.00% | 49% | 215 |
| 60-min | +0.00% | 51% | 216 |
| to close | 0.00% | 49% | 212 |
| Middle 50% of SRTS reactions | -1.08% to +1.32% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 217 |
Half of all Sensus Healthcare, Inc. news events land between -1.08% and +1.32% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when SRTS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SRTS's baseline. Nothing else.
Recent SRTS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q Sensus Healthcare, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.17% | -1.89% | |
| Form 8-K Sensus Healthcare, Inc. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +5.62% | +2.14% | |
| Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights | Press release | Business Wire | +5.62% | +2.14% | |
| Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026 | Press release | Business Wire | +0.00% | -0.68% | |
| Form 8-K Sensus Healthcare, Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.24% | |
| Form 8-K Sensus Healthcare, Inc. For: May 29 | SEC filing · Form 8-K | SEC EDGAR | +3.68% | -0.35% | |
| Form SD Sensus Healthcare, Inc. | SEC filing · Form SD | SEC EDGAR | -3.09% | -1.70% | |
| Form 10-Q Sensus Healthcare, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | -1.00% | |
| Form 8-K Sensus Healthcare, Inc. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | -1.30% | +0.33% | |
| Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights | Press release | Business Wire | -1.30% | +0.33% | |
| Form DEF 14A Sensus Healthcare, Inc. For: May 29 | SEC filing · Form DEF | SEC EDGAR | +1.43% | +2.85% | |
| Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026 | Press release | Business Wire | — | +0.00% | |
| Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract | Press release | Business Wire | -1.52% | -0.51% | |
| Form 10-K Sensus Healthcare, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +1.26% | |
| Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base | Press release | Business Wire | -1.13% | +1.26% | |
| Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology | Press release | Business Wire | +0.00% | +0.52% | |
| Form 8-K Sensus Healthcare, Inc. For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +4.88% | +5.75% | |
| Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer | Press release | Business Wire | +4.88% | +5.75% | |
| Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026 | Press release | Business Wire | -0.62% | +0.00% | |
| Form 8-K Sensus Healthcare, Inc. For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | +5.18% | -0.10% | |
| Form 8-K Sensus Healthcare, Inc. For: Jan 05 | SEC filing · Form 8-K | SEC EDGAR | +0.58% | -0.07% | |
| Sensus Healthcare Appoints Larry Biscotti to its Board of Directors | Press release | Business Wire | -0.22% | -2.44% | |
| Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco | Press release | Business Wire | -0.23% | +2.31% | |
| Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer | Press release | Business Wire | -0.25% | -1.37% | |
| Form 8-K Sensus Healthcare, Inc. For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | -1.07% | — | |
| Form 10-Q Sensus Healthcare, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -1.07% | |
| Sensus Healthcare Appoints Eric Sachetta to its Board of Directors | Press release | Business Wire | +0.82% | +8.23% | |
| Form 8-K Sensus Healthcare, Inc. For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | -1.23% | +20.00% | |
| Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026 | Press release | Business Wire | -0.44% | -9.04% | |
| Sensus Healthcare Reports Third Quarter 2025 Financial Results | Press release | Business Wire | -1.23% | +20.00% | |
| CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer | Press release | Business Wire | -0.88% | +2.35% | |
| Sensus Healthcare Announces the Passing of Director Bill McCall | Press release | Business Wire | +7.48% | -0.62% | |
| Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6 | Press release | Business Wire | +0.00% | +1.86% | |
| Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids | Press release | Business Wire | +0.00% | -2.47% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Sensus Healthcare, Inc. (SRTS) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | +2.42% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sensus Healthcare, Inc. (SRTS) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.63% | +1.89% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sensus Healthcare, Inc. (SRTS) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.27% | +0.31% | |
| Sensus Healthcare, Inc. (SRTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.71% | +0.43% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sensus Healthcare, Inc. (SRTS) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | +0.59% | |
| Sensus Healthcare, Inc. (SRTS) Investigation- Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.41% | +0.30% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sensus Healthcare, Inc. (SRTS) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.15% | +0.74% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Sensus Healthcare, Inc. (SRTS) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | +1.54% | |
| Sensus Healthcare, Inc. (SRTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | -3.49% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sensus Healthcare, Inc. (SRTS) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.28% | +4.74% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Sensus Healthcare, Inc. (SRTS) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.00% | -0.64% | |
| Form S-8 Sensus Healthcare, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.16% | -0.73% | |
| Form 10-Q Sensus Healthcare, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Sensus Healthcare, Inc. For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.59% | +2.52% | |
| Sensus Healthcare Reports Second Quarter 2025 Financial Results | Press release | Business Wire | +0.59% | +2.52% | |
| Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts | Press release | Business Wire | +2.50% | +17.71% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SRTS section they belong to.
Where else SRTS is measured.
SRTS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Entera Bio Ltd. - Ordinary Shares (ENTX) | 217 | 0.00% | 46% |
| Precipio, Inc. (PRPO) | 217 | +0.51% | 52% |
| Allied Healthcare Products, Inc. (AHPI) | 215 | 0.00% | 38% |
| Tactile Systems Technology, Inc. (TCMD) | 215 | +0.25% | 62% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Sensus Healthcare, Inc.'s median reaction calculated?
Every labeled SRTS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 217 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of SRTS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SRTS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.